Robert L. Kirkman

Interleukin-2–Receptor Blockade with Daclizumab to Prevent Acute Rejection in Renal Transplantation

F. Vincenti, Robert L. Kirkman, Susan Light et al. · New England Journal of Medicine · 1998 · 876 citations · Full text

Medicine, Immunology, Pharmacology +17

Vascular Access for Hemodialysis Patency Rates and Results of Revision

Steven B. Palder, Robert L. Kirkman, Anthony D. Whittemore et al. · Annals of Surgery · 1985 · 521 citations

Medicine, Nephrology, Surgery +13

Transmission of Hepatitis C Virus by Organ Transplantation

Brian J.G. Pereira, Edgar L. Milford, Robert L. Kirkman et al. · New England Journal of Medicine · 1991 · 382 citations · Full text

Medicine, Infectious Diseases, Hepatology +13

Prevalence of Hepatitis C Virus RNA in Organ Donors Positive for Hepatitis C Antibody and in the Recipients of Their Organs

Brian J.G. Pereira, Edgar L. Milford, Robert L. Kirkman et al. · New England Journal of Medicine · 1992 · 262 citations · Full text

Medicine, Infectious Diseases, Microbiology +11

Administration of an anti-interleukin 2 receptor monoclonal antibody prolongs cardiac allograft survival in mice.

Robert L. Kirkman, Leslie V. Barrett, Glen N. Gaulton et al. · The Journal of Experimental Medicine · 1985 · 193 citations · Full text

Life Sciences, Immunology, Pharmacology +17